Cite
Li X, Liang Q, Gao S, et al. Lenalidomide attenuates post-inflammation pulmonary fibrosis through blocking NF-κB signaling pathway. Int Immunopharmacol. 2021;103:108470doi: 10.1016/j.intimp.2021.108470.
Li, X., Liang, Q., Gao, S., Jiang, Q., Zhang, F., Zhang, R., Ruan, H., Li, S., Luan, J., Deng, R., Zhou, H., Huang, H., & Yang, C. (2021). Lenalidomide attenuates post-inflammation pulmonary fibrosis through blocking NF-κB signaling pathway. International immunopharmacology, 103108470. https://doi.org/10.1016/j.intimp.2021.108470
Li, Xiaohe, et al. "Lenalidomide attenuates post-inflammation pulmonary fibrosis through blocking NF-κB signaling pathway." International immunopharmacology vol. 103 (2021): 108470. doi: https://doi.org/10.1016/j.intimp.2021.108470
Li X, Liang Q, Gao S, Jiang Q, Zhang F, Zhang R, Ruan H, Li S, Luan J, Deng R, Zhou H, Huang H, Yang C. Lenalidomide attenuates post-inflammation pulmonary fibrosis through blocking NF-κB signaling pathway. Int Immunopharmacol. 2021 Dec 21;103:108470. doi: 10.1016/j.intimp.2021.108470. Epub 2021 Dec 21. PMID: 34952465.
Copy
Download .nbib